Post-Market Study to Assess iTind Safety in Comparison to UroLift

Clinical trial NCT04757116 · RECRUITING

Trial details

NCT number: NCT04757116
Sponsor: Olympus Corporation of the Americas
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia (BPH)

Start date: 2022-09-26
Primary completion: 2027-07-15
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.